贵州百灵股价上涨10% 创新药板块获政策支持

Group 1 - As of July 31, 2025, Guizhou Bailing's stock price reached 5.94 yuan, marking a 10.00% increase from the previous trading day [1] - The trading volume on that day was 1.1322 million lots, with a total transaction amount of 645 million yuan [1] - Guizhou Bailing operates in the traditional Chinese medicine sector of the pharmaceutical manufacturing industry, focusing on the research, production, and sales of苗药 (Miao medicine) [1] Group 2 - The company’s main products include cough syrup and soft capsules for heart and brain health, among other traditional Chinese medicine formulations [1] - Recent policy measures from the National Healthcare Security Administration support the development of innovative drugs, including a new pricing mechanism for newly launched drugs and the addition of over 100 new medical technology pricing projects [1] - These policies are expected to benefit innovative pharmaceutical companies by providing reasonable returns on investment [1] Group 3 - On July 31, Guizhou Bailing experienced a net inflow of 162 million yuan in main funds, accounting for 2.24% of its circulating market value [1]